Immunomodulation of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Renal Replacement Therapy Sasipha Tachaboon 1, Khajohn Tiranatanakul.

Slides:

Advertisements

Similar presentations

RAHelp.org: An online intervention for rheumatoid arthritis Shigaki, C.L., 1 Smarr, K., 2,3 Siva, C., 3 Ge, B., 4 Musser, D., 5 Johnson, R. 6 1 Dept. Health.

Advertisements

A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.

The Center for Acute Care Nephrology The Blended Dialysis/PICU Program Jerry Schwartz, RN, BSN, MHHA Clinical Director, PICU Cincinnati Children’s Hospital.

Protecting the heart and the kidney: Implications from the SHARP trial Dr. Christina Reith University of Oxford United Kingdom.

STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.

ECMO in CRRT – What are the Data?

Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.

 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.

Acute kidney injury R3 李岳庭 / F1 王奕淳 / VS 林景坤 Brenner and Rector's The Kidney, 8th ed P 高雄長庚腎臟科 Journal reading.

Nurse Responsibilities & Clinical Decision Making When Caring for Critically Ill Pediatric Patients Requiring Continuous Renal Replacement Therapy Colleene.

University of Southern California Department of Pharmaceutical Economics and Policy 1540 E. Alcazar Street, CHP 140 Los Angeles, CA

Non-Surgical Periodontal Therapy Reduces Coronary Heart Disease Risk Markers: A Randomized Controlled Trial Bokhari SAH, Khan AA, Butt AK, Azhar M, Hanif.

Intensive versus Conventional Glucose Control in Critical Ill Patients N Engl J Med 2009; 360: 雙和醫院劉慧萍藥師.

Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.

Jade Rotondo March 20, 2012 Grade 7 B168.  This project is going to be about our blood that functions and transfers important things in our body. Jade.

Improving Patient Outcomes GLYCEMIC CONTROL IN PERI-OPERATIVE PATIENTS UTILIZING INSULIN INFUSION PROTOCOLS.

Monthly Journal article review: Vimmi Kang PGY 2

 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.

Anticoagulation in CRRT

Stuart L. Goldstein, MD Professor of Pediatrics

Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar DrPH Batch 5 1.

Acute Kidney Injury requiring renal replacement therapy increases mortality in patients undergoing Extracorporeal Membrane Oxygenation therapy. Divisions.

Acute kidney injury and fluid overload during pediatric extracorporeal membrane oxygenation are associated with increased mortality: a report of the multi-centre.

Excessive fluid is not needed: So why is Dr. Durward so wasteful? Timothy E Bunchman MD Professor & Director Pediatric Nephrology

THE EFFECT OF TIMING OF INITITIATION OF CRRT ON PATIENTS REQUIRING EXTRA-CORPOREAL MEMBRANE OXYGENATION (ECMO) Asif Mansuri, MD, MRCPI Fellow, Division.

1 Centre for Sport and Exercise Science, Sheffield Hallam University, U. K. 2 York Trials Unit, Department of Health Sciences, University of York, U. K.

Prevention of Renal Injury by Nitric Oxide in Prolonged Cardiopulmonary Bypass A Double Blind Randomized Controlled Trial. Chong Lei & Lorenzo Berra Emanuele.

Raghavan Murugan, MD, MS, FRCP Associate Professor of Critical Care Medicine, and Clinical & Translational Science Core Faculty, Center for Critical Care.

Haemofiltration for sepsis: burial or resurrection?

Prevention of Renal Injury by Nitric Oxide in Prolonged Cardiopulmonary Bypass A Double Blind Randomized Controlled Trial Chong Lei & Lorenzo Berra Emanuele.

The Effects of Managerial Intervention on Drug Prescribing Patterns at King Chulalongkorn Memorial Hospital Limpanathikul W, Wangsaturaka D, Nantawan P,

Poster Design & Printing by Genigraphics ® A Comparison of the Effects of Etomidate and Midazolam on the Duration of Vasopressor Use in.

Carl P. Walther*, Amber S. Podoll*, Kevin W. Finkel* *The University of Texas Health Science Center at Houston Citrate Toxicity During CRRT After Massive.

Proposal of a flow-chart to avoid circuit clotting in prolonged intermittent renal replacement therapy (PIRRT): a monocentric experience 1 Vincenzo Cantaluppi,

Implementation of RRT improved the survival rate significantly, when blood urea nitrogen or serum creatinine was still low level. However, most of those.

Results Methods Abstract Number 69 Objectives 1.Nephrol Dial Transplant (2011) 26: 537–543 2.J Support Oncol 2011;9:149–155 3.N Engl J Med. 2009; 361:1627–1638.

John A. Kellum, MD, MCCM Professor of Critical Care Medicine, Medicine, Bioengineering and Clinical & Translational Science Vice Chair for Research Director,

Proposals by Paramedical Staff to Initiate Rehabilitation in Patients with Critical Illness on Mechanical Ventilation Acknowledgements This study was approved.

Careers In Nephrology Introduction Eligibility Job Prospects Remuneration

TEMPLATE DESIGN © m A CASE SERIES ANALYSIS OF RENAL OUTCOME FOR FIXED VERSUS ADJUSTABLE DOSE OF CONTINUOUS RENAL REPLACEMENT.

EFFECT OF REPEATED EXPOSURE TO SLEEP RESTRICTION ON INTERLEUKIN 6 LEVELS IN HUMANS Vrushank Dharmesh Bhatt, Moussa Diolombi, Monika Haack, Janet Mullington.

Anemia in CKD The TREAT Trial Reference Pfeiffer MA. A trial of Darbepoetin alpha in type II diabetes and chronic kidney disease. N Engl J Med. 2009;361:2019–2032.

Regional Citrate Anticoagulation Limits Sepsis-Associated Tissue Injury Through The Decreased Release Of Microvesicles From Activated Leukocytes And Platelets.

Renal Replacement Therapy for Prevention of Contrast- induced Acute Kidney Injury: A Meta-analysis of Randomized Controlled Trials Source Song K, Jiang.

An AKI project for critically ill cancer patients

University of Alabama at Birmingham

CRRT (Continuous Renal Replacement Therapy)

Surgical ICU, Heart Institute University of São Paulo

AKI in critically ill cancer patients:

Inflammatory Bowel Disease (IBD) is a Risk Factor for Extrahepatic Cholangiocarcinoma (ECC) in Subjects Without Underlying Primary Sclerosing Cholangitis.

Copenhagen University Hospital Rigshospitalet, Denmark

Quantification and Dosing of Renal Replacement Therapy in Acute Kidney Injury: A Reappraisal Blood Purif 2017;44: DOI: / Fig.

Significant Differences in Risk Factors for Perihilar Cholangiocarcinoma (CCA) Compared to Distal CCA: Rationale for Approaching Them as Distinct Entities.

Larissa Registry on CAS and CEA:

Effect of Acute Kidney Injury on Chronic Kidney Disease Progression and Proteinuria: Initial Results from a Pilot Study Horne K1, Scott R1, Packington.

DEBATE: Timing of CRRT in Critical Care

Continuous Renal Replacement Therapy Education to Improve Parental Understanding and Satisfaction Alyssa A. Riley,1 Ayse A. Arikan,1 Amelia G. Allsteadt,2.

OUTCOMES OF REGIONAL CITRATE ANTICOAGULATION (RCA) IN PEDIARTIC CONTINUOUS RENAL REPLACEMENT THERAPY (pCRRT) IN A SINGLE CENTER Issa Alhamoud, Diane Gollhofer,

Objectives Early initiation of continuous renal replacement therapy

Nat. Rev. Nephrol. doi: /nrneph

PROACT-4 Trial design: Patients enroute to the hospital with acute chest pain were randomized to point of care troponin testing (n = 305) vs. usual care.

Summary of Recommendation Statements

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

A Six-hour Hemodialysis Without a Significant Increase in Dialysis Dose, as Judged by Kt/V, Can Reduce the Dosage of Erythropoietin Department of Kidney.

Monthly Journal article review: Vimmi Kang PGY 2

Continuous renal replacement therapy in the critically ill patient

Abstract No. 452.

Children’s Memorial Hospital Northwestern University

Volume 60, Issue 3, Pages (September 2001)

Khai Hoan Tram, Jane O’Halloran, Rachel Presti, Jeffrey Atkinson

Presentation transcript:

Immunomodulation of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Renal Replacement Therapy Sasipha Tachaboon 1, Khajohn Tiranatanakul 2 and Nattachai Srisawat 3 1Master of Science Program in Medical Sciences, Faculty of Medicine, Chulalongkorn University, 2Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, and 3Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Thai Red Cross.

Background Acute Kidney Injury [AKI] is a common health problem in ICU. AKI can also lead to decreased survival and increased risk of mortality in critically ill patients. Continuous Renal Replacement Therapy [CRRT] is considered as a standard treatment for AKI patients. Regional citrate anticoagulation [RCA] is an alternative anti-coagulation for CRRT. It is associated with inflammatory cell functions improving patient survival. RCA potentially affects the immunomodulation.

We aim to study the effect of regional citrate anticoagulation in immune response in patients with AKI undergoing CRRT. Objective

This prospective randomized controlled trial was performed of 30 AKI patients requiring CRRT at King Chulalongkorn Memorial hospital. The participants were randomized to either RCA group [n = 15] or control group [n = 15]. Blood samples were collected to measure CD 11b, HLA-DR, C3a, C5a and PAI-1 at baseline, six hours and 24 hours after start of CRRT. Method

A total of AKI patients with CRRT were recruited and randomized into control and regional citrate anticoagulation group. The demographic data and baseline are not different in each groups. Regional citrate anticoagulation group significantly results in high percentage of the reduction in CD11b at 24 hours (-41.5 vs. 7.1 %, p = 0.02), concordantly with HLA-DR at 24 hours (-5.17 vs %, p = 0.02) and PAI-1 at 24 hours ( vs , p = 0.03). Moreover, biomarkers including c3a and c5a decreased over time during CRRT. Results

Functions of cell surface markers among two groups.

ggf Results 28-days survival in AKI patients with CRRT among two groups.

RCA in CRRT reduced inflammatory effects of the immune system and mortality rate in AKI patients. RCA provides potential benefits for CRRT in AKI. Conclusion

Acknowledgement Master of Science Program in Medical Sciences, Faculty of Medicine, Chulalongkorn University. Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University. Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Thai Red Cross. Graduate grant from National Research Council of Thailand (NRCT) 2558.